| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2019/10/04 | 06:04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/09/24 | 19:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/09/24 | 06:10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/09/24 | 06:06 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/09/14 | 06:19 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/08/27 | 23:03 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/08/17 | 06:02 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/08/15 | 06:12 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/08/15 | 05:16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/23 | 22:59 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/23 | 22:58 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/23 | 06:21 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/19 | 03:12 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/18 | 06:27 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/17 | 05:01 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/13 | 06:24 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/12 | 06:30 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/12 | 06:28 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/11 | 06:21 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/11 | 06:19 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/09 | 06:26 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/04 | 05:06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/04 | 05:05 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/03 | 23:00 | GlobeNewswire Inc. | Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019 | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/07/03 | 06:04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/06/07 | 23:28 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/06/07 | 19:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/06/07 | 06:16 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/06/04 | 06:22 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 2019/05/23 | 06:17 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |